Autophagy and mTOR — The Molecular Biology of Fasting

In 2016, the Nobel Prize in Physiology or Medicine was awarded to Yoshinori Ohsumi for his discoveries of the molecular machinery of autophagy — the cellular self-cleaning process by which cells degrade and recycle their own damaged components. Ohsumi's yeast-genetic screens in the 1990s identified the ATG (autophagy-related) genes that encode the membrane-trafficking machinery for the formation of autophagosomes — the double-membrane vesicles that engulf damaged organelles, misfolded proteins, and even invading intracellular pathogens, deliver them to the lysosome for degradation, and recycle the molecular components as amino acids, fatty acids, and nucleotides. Autophagy is the cellular equivalent of a recycling program. It is the most powerful endogenous mechanism humans possess for managing the accumulated damage of aging, and fasting is the single most powerful physiological inducer of it. The control system — mTOR signaling — is what determines moment-by-moment whether a cell is in growth-and-synthesis mode or maintenance-and-recycling mode.

Table of Contents

  1. What Autophagy Actually Is
  2. The Ohsumi Discovery and the ATG Genes
  3. mTOR — The Master Growth-vs-Maintenance Switch
  4. AMPK — The Energy-Depletion Sensor
  5. Leucine and Amino-Acid mTOR Activation
  6. Insulin, IGF-1, and PI3K/Akt Branch
  7. Selective Autophagy (Mitophagy, Pexophagy, Xenophagy)
  8. Disease Implications — Cancer, Neurodegeneration, Aging
  9. How to Maximize Autophagy in Practice
  10. Key Research Papers
  11. Connections

What Autophagy Actually Is

Cells contain organelles that wear out, proteins that misfold, lipid droplets that accumulate, and the occasional intracellular pathogen. Without a mechanism to dispose of and recycle this damaged material, cells would slowly fill with debris, lose function, and eventually die — which is essentially what happens in aging tissues, and what happens dramatically in neurodegenerative diseases where damaged proteins (amyloid-beta in Alzheimer's, alpha-synuclein in Parkinson's, mutant huntingtin in Huntington's) accumulate in neurons.

Autophagy — from the Greek auto ("self") + phagein ("to eat") — is the cell's solution. There are three distinct mechanisms:

  1. Macroautophagy — the most studied form. A flat membrane sheet (the phagophore) extends around a piece of cytoplasm containing damaged organelles or misfolded proteins, fuses with itself to form a double-membrane vesicle called an autophagosome, and then fuses with a lysosome where acid hydrolases degrade the cargo. The amino acids, fatty acids, and nucleotides released by degradation are recycled back to the cell for the synthesis of fresh components. This is what most people mean by "autophagy" in the popular fasting literature.
  2. Microautophagy — the lysosomal membrane directly invaginates to engulf small cytoplasmic contents. Less well characterized.
  3. Chaperone-mediated autophagy (CMA) — specific proteins bearing a KFERQ motif are recognized by the cytosolic chaperone HSC70 and delivered to the lysosome via the LAMP-2A receptor. This is a targeted disposal mechanism for specific proteins, not a bulk recycling system.

All three are upregulated during fasting and downregulated during the fed state. The macroautophagy response to fasting is the most dramatic — autophagic flux can increase 4-10-fold in liver, heart, and muscle tissue within 24-48 hours of fasting in mouse models. Human data are more limited because measuring autophagy in human tissue requires biopsy, but indirect surrogate markers (serum LC3-II, autophagy-related gene expression in PBMCs) show parallel changes.

Back to Table of Contents

The Ohsumi Discovery and the ATG Genes

Yoshinori Ohsumi's laboratory at the University of Tokyo began studying autophagy in the late 1980s, when the basic phenomenon of vacuolar protein degradation was known but the molecular machinery was completely opaque. Ohsumi made the brilliant methodological decision to study autophagy in baker's yeast (Saccharomyces cerevisiae) — an organism that could be subjected to systematic genetic screens.

His 1992 Journal of Cell Biology paper described starved yeast cells accumulating autophagic bodies in their vacuoles, visible under light microscopy when vacuolar protease activity was blocked. With this assay, his lab conducted a mutagenesis screen and identified 15 yeast genes required for autophagy — the original ATG genes (atg1 through atg15). Subsequent work expanded the list to over 40 ATG genes and identified the mammalian homologs.

The molecular cascade Ohsumi and others worked out:

Every step is conserved from yeast through mammals — a striking testament to the evolutionary antiquity of the autophagy machinery and its centrality to eukaryotic cell biology.

Back to Table of Contents

mTOR — The Master Growth-vs-Maintenance Switch

mTOR (mechanistic target of rapamycin, formerly "mammalian target of rapamycin") is a serine/threonine kinase that integrates signals about nutrient sufficiency, energy state, growth factors, and oxygen availability, and determines whether the cell will pursue growth-and-proliferation or maintenance-and-recycling.

mTOR exists in two functionally distinct complexes:

The fed state — when blood glucose, insulin, IGF-1, and circulating amino acids (especially leucine) are all elevated — pushes mTORC1 to maximal activity. Protein synthesis runs. Autophagy is suppressed. The cell builds. The fasted state — when all four signals decline — releases mTORC1 inhibition of ULK1. Autophagy initiates. The cell cleans house and recycles its components.

This reciprocal architecture is why fasting is the most powerful physiological autophagy inducer. There is no supplement or drug short of rapamycin itself that produces the equivalent simultaneous downregulation of all four mTORC1 inputs.

Back to Table of Contents

AMPK — The Energy-Depletion Sensor

If mTOR is the nutrient-sensing master, AMP-activated protein kinase (AMPK) is the energy-state sensor that operates as its functional opposite. AMPK is allosterically activated by AMP and ADP — the products of ATP hydrolysis. When cellular ATP is being used faster than it is being produced, the AMP:ATP ratio rises, and AMPK switches on.

Activated AMPK has three major actions relevant to fasting:

  1. Direct ULK1 activation — AMPK phosphorylates ULK1 at Ser317 and Ser777, directly activating it and overriding the mTORC1 inhibition. This is the direct AMPK-driven path to autophagy.
  2. Indirect mTORC1 inhibition — AMPK phosphorylates and activates TSC2, which converts Rheb-GTP to Rheb-GDP and thereby inhibits mTORC1. AMPK also directly phosphorylates Raptor (within mTORC1), causing 14-3-3 binding and further mTORC1 inhibition.
  3. Metabolic reprogramming — AMPK phosphorylates and inhibits acetyl-CoA carboxylase (blocking fatty-acid synthesis), activates carnitine palmitoyltransferase 1 (driving fatty acid oxidation), activates GLUT4 translocation (increasing glucose uptake in muscle), and increases mitochondrial biogenesis through PGC-1alpha.

The drug metformin (the front-line type-2-diabetes therapy) activates AMPK as its proposed primary mechanism, which is why metformin produces some of the same metabolic signatures as fasting — improved insulin sensitivity, increased fat oxidation, modest autophagy induction. The longevity-research interest in metformin (the TAME trial) is essentially the hypothesis that pharmacological AMPK activation could partially replicate the fasting longevity signal.

Exercise — particularly intense exercise — also activates AMPK by transiently elevating the AMP:ATP ratio. This is part of why the combination of intermittent fasting and exercise produces synergistic effects on metabolic health — both interventions independently activate AMPK, and the effects compound.

Back to Table of Contents

Leucine and Amino-Acid mTOR Activation

Among the inputs to mTORC1, amino acids — and particularly the branched-chain amino acid leucine — have an outsized regulatory effect. Leucine binds to the cytosolic sensor sestrin2, releasing sestrin's inhibition of GATOR2, which permits Rag GTPase-mediated recruitment of mTORC1 to the lysosomal surface where it can be activated by Rheb.

Practical implication: leucine breaks a fast in terms of mTOR signaling, even in trivial amounts. A small protein snack of 5-10 grams of complete protein (about 1 g of leucine) is sufficient to reactivate mTORC1 and shut down autophagy. This is why "just a little protein" during a fasting window is not metabolically trivial — it specifically eliminates the autophagy benefit even if the calorie content is negligible.

Conversely, ketogenic diets and very-low-protein diets (the rationale behind some fasting-mimicking diet protocols) keep leucine low even while providing some calories, allowing mTORC1 suppression to persist. This is why the FMD is designed to be 9-11% protein — low enough to keep mTORC1 mostly off while providing enough food intake to improve safety and tolerability.

The corollary for muscle health: leucine is also the most powerful trigger of muscle protein synthesis. The leucine threshold of approximately 2.5-3 g per meal is required to maximally stimulate MPS in healthy young adults; older adults need approximately 3-4 g per meal due to anabolic resistance. For practitioners trying to combine fasting with muscle maintenance, the strategy is to time the fed-window meals to deliver supraphysiologic leucine pulses (which efficiently support MPS within the 8-hour window) while keeping the fasting window strictly leucine-free.

Back to Table of Contents

Insulin, IGF-1, and PI3K/Akt Branch

The second major fed-state mTOR input is the insulin / IGF-1 / PI3K / Akt growth-factor signaling axis. Insulin and IGF-1 bind their respective receptor tyrosine kinases on the cell surface. The activated receptors recruit insulin receptor substrate (IRS1/2), which activates phosphoinositide 3-kinase (PI3K). PI3K phosphorylates membrane PIP2 to PIP3, which recruits Akt (also called PKB). PDK1 then phosphorylates Akt at Thr308 and mTORC2 phosphorylates Akt at Ser473, activating Akt.

Activated Akt phosphorylates and inactivates TSC2 (the inhibitor of mTORC1 noted above). With TSC2 inactivated, Rheb-GTP accumulates and activates mTORC1. The PI3K/Akt/mTORC1 cascade is the dominant signaling pathway that links systemic anabolism (insulin from a meal, IGF-1 from growth hormone action) to cell-autonomous protein synthesis.

The longevity implication: lifelong reduction in IGF-1 signaling is associated with extended lifespan across species from C. elegans (the daf-2 / age-1 insulin/IGF-1 pathway mutants discovered by Cynthia Kenyon) through mice (long-lived Ames dwarf and Snell dwarf mutants have low IGF-1) to humans (Laron syndrome patients with congenital growth-hormone receptor deficiency have strikingly low cancer incidence, per Guevara-Aguirre and Longo's Ecuadorian cohort).

Fasting acutely lowers insulin and IGF-1 and chronically reduces fasting insulin via improved insulin sensitivity, intersecting with the same longevity-associated signaling reductions. The fasting / caloric-restriction longevity literature and the IGF-1 longevity literature are essentially studying the same fundamental phenomenon from different methodological angles.

Back to Table of Contents

Selective Autophagy (Mitophagy, Pexophagy, Xenophagy)

Bulk autophagy degrades cytoplasmic material indiscriminately. But the autophagy machinery can also be selectively targeted to specific cargo, producing several specialized clearance systems:

Fasting upregulates all of these selective autophagy pathways, not just the bulk macroautophagy. Mitophagy in particular is dramatically increased — one of the proposed mechanisms by which fasting improves mitochondrial quality and function in aged tissue.

Back to Table of Contents

Disease Implications — Cancer, Neurodegeneration, Aging

Back to Table of Contents

How to Maximize Autophagy in Practice

  1. Extended fasting (24-72 hours) — the most powerful physiological autophagy inducer. See the extended-fasts page for protocols.
  2. Daily time-restricted eating with the longest tolerable fasting window — 16:8 produces modest autophagy; tighter windows produce more.
  3. Ketogenic diet — chronic carbohydrate restriction with adequate fat keeps insulin and mTOR low even in the fed state, producing modest baseline autophagy upregulation.
  4. Strict avoidance of leucine during the fasting window — no protein, no broth with meat protein, no BCAA supplements during the fast. Even a few grams of leucine reactivates mTORC1 and shuts down autophagy.
  5. Exercise during the fast — particularly fasted aerobic and resistance exercise. AMPK activation from exercise compounds with the fasting-induced AMPK activation.
  6. Coffee and tea — coffee in particular is a modest autophagy inducer through caffeine and chlorogenic acid effects on AMPK and mTOR. Compatible with fasting.
  7. Spermidine-rich foods during the fed window — wheat germ, aged cheese, and fermented soy products are concentrated sources of spermidine, a polyamine that induces autophagy and has been shown to extend lifespan in multiple species.
  8. Avoid frequent snacking — even a small calorie-bearing snack interrupts the fasting state and reactivates mTOR. Three discrete meals in an 8-10 hour window is metabolically better than 5-6 small snacks across the day, even at identical total calories.

Back to Table of Contents

Key Research Papers

  1. Ohsumi Y (2014). Historical landmarks of autophagy research. Cell Research. — PubMed
  2. Mizushima N, Komatsu M (2011). Autophagy: renovation of cells and tissues. Cell. — PubMed
  3. Saxton RA, Sabatini DM (2017). mTOR signaling in growth, metabolism, and disease. Cell. — PubMed
  4. Hardie DG, Ross FA, Hawley SA (2012). AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nature Reviews Molecular Cell Biology. — PubMed
  5. Kim J et al. (2011). AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology. — PubMed
  6. Sancak Y et al. (2008). The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science. — PubMed
  7. Wolfson RL et al. (2016). Sestrin2 is a leucine sensor for the mTORC1 pathway. Science. — PubMed
  8. Levine B, Kroemer G (2019). Biological functions of autophagy genes: a disease perspective. Cell. — PubMed
  9. Madeo F et al. (2018). Spermidine in health and disease. Science. — PubMed
  10. Harrison DE et al. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. — PubMed
  11. Pickrell AM, Youle RJ (2015). The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron. — PubMed
  12. Bjedov I et al. (2010). Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metabolism. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents